121 related articles for article (PubMed ID: 7522136)
1. SR1 assays of alpha-fetoprotein, carcinoembryonic antigen, and prostate-specific antigen compared with corresponding established commercial assays.
Jolley NL; Bacarese-Hamilton T
Clin Chem; 1994 Jun; 40(6):895-9. PubMed ID: 7522136
[TBL] [Abstract][Full Text] [Related]
2. Measurement of alpha-fetoprotein, carcinoembryonic antigen and prostate-specific antigen in serum and heparinised plasma by enzyme immunoassay on the fully automated serono SR1 analyzer.
Cattini R; Cooksey M; Robinson D; Brett G; Bacarese-Hamilton T; Jolley N
Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):517-24. PubMed ID: 7692986
[TBL] [Abstract][Full Text] [Related]
3. Multicentre evaluation of the Serono SR1 assay for prostate specific antigen.
Plebani M; Robba L; Pursglove H; Gualandris L; Jolley N
Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):113-7. PubMed ID: 7543293
[TBL] [Abstract][Full Text] [Related]
4. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
[TBL] [Abstract][Full Text] [Related]
5. Measurement of prostate-specific antigen in serum using four different immunoassays.
Cattini R; Robinson D; Gill O; Jolley N; Bacarese-Hamilton T
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):181-5. PubMed ID: 7518258
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three commercial PSA assays: results of restandardization of the Ciba Corning method.
Brawer MK; Bankson DD; Haver VM; Petteway JC
Prostate; 1997 Mar; 30(4):269-73. PubMed ID: 9111605
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of MARK BTM for Quantitative Measurement of Three Tumor Markers: Prostate Specific Antigen, Alpha Fetoprotein, and Carcinoembryonic Antigen.
Hwang H; Kim J; Choi J; Kim KH; Han HS
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414747
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
Vessella RL; Noteboom J; Lange PH
Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
[TBL] [Abstract][Full Text] [Related]
9. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
Wener MH; Daum PR; Brawer MK
Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
[TBL] [Abstract][Full Text] [Related]
10. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
[TBL] [Abstract][Full Text] [Related]
11. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL
Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of a new chemiluminescent assay for prostate specific antigen.
Dasgupta A; Wells A; Datta P
J Clin Lab Anal; 2000; 14(4):164-8. PubMed ID: 10906769
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen.
Schreiber WE; Endres DB; McDowell GA; Palomaki GE; Elin RJ; Klee GG; Wang E
Arch Pathol Lab Med; 2005 Mar; 129(3):331-7. PubMed ID: 15737027
[TBL] [Abstract][Full Text] [Related]
14. Assay variability in serum prostate-specific antigen determination.
Brawer MK; Daum P; Petteway JC; Wener MH
Prostate; 1995 Jul; 27(1):1-6. PubMed ID: 7541527
[TBL] [Abstract][Full Text] [Related]
15. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.
Leewansangtong S; Goktas S; Lepoff R; Holthaus K; Crawford ED
Urology; 1998 Sep; 52(3):467-9. PubMed ID: 9730462
[TBL] [Abstract][Full Text] [Related]
16. Some analytical considerations on the measurement of prostate-specific antigen.
Blijenberg BG; Kranse R; Eman I; Schröder FH
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):817-21. PubMed ID: 8933105
[TBL] [Abstract][Full Text] [Related]
17. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.
Jacobsen SJ; Lilja H; Klee GG; Wright GL; Pettersson K; Oesterling JE
Urology; 1994 Oct; 44(4):512-8. PubMed ID: 7524236
[TBL] [Abstract][Full Text] [Related]
18. Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500.
Zur B; Holdenrieder S; Walgenbach-Brünagel G; Albers E; Stoffel-Wagner B
Clin Lab; 2012; 58(1-2):97-105. PubMed ID: 22372351
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen, alpha-fetoprotein, and prostate-specific antigen in the sera of industrial workers exposed to phenol, formaldehyde, urea, and mixed vapors.
El Far M; El Naggar M; Elkhawaga OA; Yahya R; Allam A; Khalifa A
Inhal Toxicol; 2006 Dec; 18(13):1041-6. PubMed ID: 16966304
[TBL] [Abstract][Full Text] [Related]
20. Variance function as basis for assessment of test performance: methodological studies with two assays of prostate-specific antigen.
Hänseler E; Keller B; Keller H
Clin Chem; 1994 Nov; 40(11 Pt 1):2046-52. PubMed ID: 7525116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
